Ruptured large hepatic cyst with elevated serum and ascites CA19-9 level

被引:1
作者
Mizukami, Ryosuke [1 ]
Nakazawa, Akiko [1 ]
Einama, Takahiro [1 ]
Kariya, Risa [1 ]
Ohara, Mayuko [1 ]
Ichio, Koki [1 ]
Konno, Fukumi [1 ]
Kobayashi, Kazuki [1 ]
Yonamine, Naoto [1 ]
Fujinuma, Ibuki [1 ]
Tsunenari, Takazumi [1 ]
Takihata, Yasuhiro [1 ]
Takao, Mikiya [1 ]
Shinto, Eiji [1 ]
Ueno, Hideki [1 ]
Kishi, Yoji [1 ]
机构
[1] Natl Def Med Coll, Dept Surg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan
来源
JOURNAL OF SURGICAL CASE REPORTS | 2024年 / 2024卷 / 08期
关键词
large hepatic cyst; CA19-9; ruptured hepatic cyst; laparoscopic fenestration;
D O I
10.1093/jscr/rjae309
中图分类号
R61 [外科手术学];
学科分类号
摘要
Tumor markers such as carbohydrate antigen 19-9 (CA19-9) are generally useful in ruling out malignancy of hepatic cysts. The patient was a 72-year-old man who had a ruptured liver cyst in the right liver, which had been noted since he was 67 years old at another hospital. The initial laboratory tests demonstrated elevated CA19-9 (193 784.3 U/mL). We made the diagnosis with a simple ruptured liver cyst from magnetic resonance imaging and cytological examination of ascites, and laparoscopic fenestration with drainage of the abdominal fluid was performed. Pathological diagnosis of the resected wall cyst was non-parasitic simple hepatic cyst with acute inflammation and hemorrhage. The patient's serum levels of CA19-9 were 164.0 U/mL on postoperative day 23. The follow-up abdominal computed tomography scan performed 2 months later did not any finding of tumor.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Nonelevation of serum CA 19-9 level in a true nonparasitic splenic cyst
    Pinder, Richard M.
    Thomas, Rachel
    Lyndon, Phillip J.
    Chapple, Keith S.
    SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES, 2006, 16 (03) : 190 - 194
  • [22] Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study
    Dong, Qian
    Yang, Xiang-hong
    Zhang, Yao
    Jing, Wei
    Zheng, Li-qiang
    Liu, Yun-peng
    Qu, Xiu-juan
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2014, 12
  • [23] Serum CA19-9 determination in the management of pancreatic cancer
    vandenBosch, RP
    vanEijck, CHJ
    Mulder, PGH
    Jeekel, J
    HEPATO-GASTROENTEROLOGY, 1996, 43 (09) : 710 - 713
  • [24] Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
    Chen, CC
    Yang, SH
    Lin, JK
    Lin, TC
    Chen, WS
    Jiang, JK
    Wang, HS
    Chang, SC
    JOURNAL OF SURGICAL RESEARCH, 2005, 124 (02) : 169 - 174
  • [25] CA19-9: A possible serum marker for embryonal carcinoma
    Tsuruta, T
    Ogawa, A
    Ishii, K
    Ikado, S
    UROLOGIA INTERNATIONALIS, 1997, 58 (01) : 20 - 24
  • [26] High preoperative serum CA19-9 level is predictive of poor prognosis for patients with colorectal liver oligometastases undergoing hepatic resection
    Zhenhai Lu
    Jianhong Peng
    Zhiqiang Wang
    Zhizhong Pan
    Yunfei Yuan
    Desen Wan
    Binkui Li
    Medical Oncology, 2016, 33
  • [27] High preoperative serum CA19-9 level is predictive of poor prognosis for patients with colorectal liver oligometastases undergoing hepatic resection
    Lu, Zhenhai
    Peng, Jianhong
    Wang, Zhiqiang
    Pan, Zhizhong
    Yuan, Yunfei
    Wan, Desen
    Li, Binkui
    MEDICAL ONCOLOGY, 2016, 33 (11)
  • [28] Elevation of serum CA19-9 levels in benign diseases
    Ito, S
    Gejyo, F
    INTERNAL MEDICINE, 1999, 38 (11) : 840 - 841
  • [29] Differential diagnostic roles of the serum CA19-9, total bilirubin (TBIL) and the ratio of CA19-9 to TBIL for benign and malignant
    Liu, Wei
    Liu, Qiaofei
    Wang, Wenqin
    Wang, Penghui
    Chen, Jieming
    Hong, Tao
    Zhang, Ning
    Li, Binglu
    Qu, Qiang
    He, Xiaodong
    JOURNAL OF CANCER, 2018, 9 (10): : 1804 - 1812
  • [30] Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei
    Liang, Lei
    Fang, Jingyang
    Han, Xuedi
    Zhai, Xichao
    Song, Yan
    Lu, Yiyan
    Zhang, Qian
    Ma, Ruiqing
    FRONTIERS IN ONCOLOGY, 2021, 11